Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 181

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Osteopenia in HIV-infected patients: is it the disease or is it the treatment?

Knobel, Hernando, Guelar, Ana, Vallecillo, Gabriel, Nogués, Xavier, Díez, Adolfo·2001·AIDS

Abstract

Bone loss is a normal feature of aging. Accelerated bone demineralization is a multifactorial process; recent reports have suggested that HIV infection, perhaps in association with protease inhibitor (PI) therapy, is an additional risk factor for osteopenia [1,2]. However, changes in bone mineral metabolism, bone histomorphometry or bone mineral density had been described in HIV-infected patients before the era of highly active antiretroviral therapy (HAART) [3–5]. The aim of this study is to define the role of HIV infection and antiretroviral therapy in the development of bone mineral loss. A cross-sectional study was performed with the following patients enrolled: 80 HIV-infected patients [58 men, 22 women, mean age (SD) 41 years (± 8)]; 26 did not receive treatment; 37 were on HAART that included a PI; 17 were on HAART without a PI (two nucleoside reverse transcriptase inhibitors plus one non-nucleoside reverse transcriptase inhibitor). One hundred healthy seronegative adults matched by age and sex served as controls. Patients with known factors of osteopenia were excluded (recent history of extended bed rest, previous diagnosis of metabolic bone disease, renal insufficiency, hepatic failure, diabetes mellitus or previous diagnosis of other endocrine disease, moderate or severe nutritional alteration, and severe alcohol consumption). Hologic QDR-4500 SL dual energy X-ray absorptiometry was used to determine the bone mineral density (BMD) of the lumbar spine (L1–L4) and proximal femur, with T and Z scores (T score represents a SD in BMD within the mean of the population at 30; Z score represents a SD in BMD within the mean of the same age and sex group). Using World Health Organization definitions of osteopenia and osteoporosis, we classified the patients into the following categories: normal: T score greater than −1; osteopenic: T score from −1 to −2.5; and osteoporotic: T score less than −2.5. Non-parametric statistical tests (Kruskal–Wallis) were used to compare Z scores for spinal and hip BMD between groups. Normally distributed variables were compared using an analysis of variance. Chi-square and Fisher's exact test were used for categorical variables. Pearson's correlation coefficient was used to evaluate weight, body mass index, duration of therapy, CD4 cell count, and viral load in relation to BMD. The characteristics of the 180 subjects included in the study and its most relevant results are summarized in Table 1.Table 1: Characteristics of the 180 patients included in the study. No differences were found in HIV-infected patients, irrespective of the treatment or type of treatment; however, the HIV-infected patients have lower BMD compared with healthy adults; the difference in BMD Z score between healthy adults and HIV patients was: in the lumbar spine: −0.43 [ P = 0.001; 95% confidence interval (CI) −0.7 to −0.2]; in the femoral neck: −0.68 (P = 0.0001; 95% CI −0.91 to −0.44). BMD was not correlated with HIV categories, viral load, CD4 cell count, duration of therapy, or the presence of lipodystrophy, and was correlated with weight and body mass index (r = 0.3; P = 0.02). In relation to the potential role of individual antiretroviral agents on decreased BMD, we found that patients exposed to indinavir (17 patients, as the only PI used) have lower Z scores in the femoral neck compared with treated patients who have not been exposed to indinavir (−1.4 versus −0.7; P = 0.02). Osteopenia was present in 25% of healthy adults and in 67.5% of HIV-infected patients [ P = 0.00001; odds ratio (OR) 6.2; 95% CI 3.1–12.6]. Osteoporosis was present in 5% of healthy adults and in 21.2% of HIV-infected patients (P = 0.00009; OR 5.1; 95% CI 1.7–18.5). Differences in osteopenia or osteoporosis did not reach statistical significance among the HIV patient groups. In our study, a decrease in BMD and a higher rate of osteopenia and osteoporosis was found in HIV-infected patients compared with non-HIV patients. No clear association was found in relation to the use of HAART or the type of HAART used. Studies made before the HAART era and a more recent study obtained similar conclusions [3–6]. The hypothesis that the systemic activation of T cells in vivo leads to an osteoprotegerin ligand-mediated increase in osteoclastogenesis and bone loss [7] may explain the interaction of HIV infection and bone mineralization. The lack of differences in the rate of osteopenia and osteoporosis found in HIV-infected patients irrespective of the treatment received has the limitation of the relatively small population included in the study. The difference observed in patients exposed to indinavir with respect to other patients treated in the femoral neck is a very preliminary observation; however, indinavir is the only PI known to alter the activity of osteoblast alkaline phosphatase in vitro[8]. The aetiology of bone loss in HIV-infected patients, the role of specific class toxicity, the clinical implications and the therapeutic or p

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1097/00002030-200104130-00022

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 2 references

Cited by

See all 181

Metadata

Authors
Knobel, H., Guelar, A., Vallecillo, G., Nogués, X., & Díez, A.
Venue
AIDS
Published
2001-04
Volume
15
Issue
6
Pages
807-808
ISSN
0269-9370 (ISSN-L)
OpenAlex
W2027372478
Cited by
181
References
2
FWCI
13.56
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Osteopenia in HIV-infected patients: is it the disease or is it the treatment? https://app.cochat.ai/papers/10.1097/00002030-200104130-00022
The paper
Knobel, H., Guelar, A., Vallecillo, G., Nogués, X., & Díez, A. (2001). Osteopenia in HIV-infected patients: is it the disease or is it the treatment? AIDS. https://doi.org/10.1097/00002030-200104130-00022

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.